74 completed, 7 unknown, 2 recruiting, 2 withdrawn. 43 Phase 1, 33 Not applicable, 5 Early Phase 1, 2 Phase 2, 1 Phase 3.
Follow Bioavailability: new trials by email Literature Review of Bioavailability trials Research Report on Bioavailability
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Trigonelline Monohydrate on NAD+ Metabolism, Pharmacokinetics, Safety, and Tolerability in Healthy Adults Nicotinamide Mononucleotide (NMN), Placebo, Trigonelline Monohydrate - NAD+ Metabolism, Pharmacokinetics | Phase 1 | Not yet recruiting | dsm-firmenich Switzerland AG | 60 | 2026-10-01 | 2026-10-19 |
| A Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions Advil Tablet (Mini) (Test Product), Advil Tablet (Reference Product) - Bioequivalence, Bioavailability | Phase 1 | Completed | HALEON | 68 | 2025-12-17 | 2026-09-23 |
| CreNeuroS™️CNS Fish Oil Plus Softgels Compared to Vascepa® Capsules and Deplin® Capsules in a Pharmacokinetic, Single Dose Evaluation on Healthy Adult Human Subjects Under Fasting Conditions CreNeuroS CNS Fish Oil Plus Softgel [380 mg of fish oil contains Eicosapentaenoic Acid (EPA) （as EE）342 mg; L-5- Methyltetrahydrofolate 1.875 mg; other Vitamins and Minerals], Vascepa® (Icosapent ethyl) 1000 mg Capsules, Deplin® (L-methylfolate Calcium) 7.5 mg Capsules - Bioavailability | Not applicable | Enrolling by invitation | Sichuan Credit Pharmaceutical Co., Ltd. | 14 | 2025-01-03 | 2025-01-23 |
| Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects RLF-OD032, Kuvan - Bioavailability | Phase 1 | Completed | APR Applied Pharma Research s.a. | 16 | 2024-07-30 | 2025-06-12 |
| Bioavailability of Ration Items Containing Tart Cherry Extract Fruit Bar, Powdered Drink, Commercially available 100% tart cherry juice - Bioavailability | Not applicable | Recruiting | United States Army Research Institute of Environmental Medicine | 15 | 2024-06-14 | 2025-12-29 |
| An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects BH006 for injection, Fosaprepitant for injection+Palonosetron hydrochloride injection - Bioavailability | Early Phase 1 | Unknown | Zhuhai Beihai Biotech Co., Ltd | 40 | 2024-05-01 | 2024-05-24 |
| Bioavailability of Aronia Melanocarpa Aronia Melanocarpa extract - Bioavailability, Kinetics | Not applicable | Unknown | Maastricht University Medical Center | 16 | 2024-03-25 | 2024-06-13 |
| Enhanced Absorption of curQ+ or Liposomal Curcumin Formulations Versus 95% Curcumin Powder in Healthy Subjects 95% curcumin extract powder, curQ+ curcumin formulation, liposomal curcumin formulation - Bioavailability | Not applicable | Completed | ESM Technologies, LLC | 25 | 2024-03-01 | 2026-08-07 |
| Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β) Low dose, High dose - Bioavailability | Not applicable | Completed | Universidad Católica San Antonio de Murcia | 12 | 2024-02-12 | 2024-05-20 |
| Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects Filgotinib - Bioavailability | Phase 1 | Completed | Lakefront Biotherapeutics NV | 12 | 2023-09-22 | 2023-11-29 |
| Bioavailability Study of Hemp Phenolics Low dose dietary fiber, High dose dietary fiber - Bioavailability, Metabolites | Not applicable | Unknown | Brightseed | 10 | 2023-09-15 | 2023-10-24 |
| Curcumin and Retinal Study Low curcumin group, High curcumin group - Bioavailability, Gut Microbiome | Phase 1 / Phase 2 | Recruiting | Texas Tech University Health Sciences Center | 60 | 2023-08-21 | 2026-01-13 |
| Oral Bioavailability of Two Melatonin Supplements Melatonin with phenyl capsaicin, Melatonin without phenyl capsaicin - Bioavailability | Not applicable | Completed | Fundació Eurecat | 12 | 2023-05-30 | 2023-08-01 |
| A Stable Isotope Study to Evaluate the Bioavailability of an Oat Protein-based Iron Delivery System 54Fe SO4, 57Fe Oat-1, 58Fe Oat-2 - Bioavailability | Not applicable | Completed | The Rainforest Company | 52 | 2023-04-03 | 2024-04-11 |
| Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015 IP2015 - Bioavailability | Phase 1 | Unknown | Initiator Pharma | 12 | 2023-02-16 | 2023-02-15 |
| Bioavailability of Select Nutrients From Two Formulations of a Multivitamin/Mineral Supplement Formulation #1, Formulation #2 - Bioavailability | Not applicable | Completed | Midwest Center for Metabolic and Cardiovascular Research | 24 | 2022-12-23 | 2023-05-17 |
| Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation Linaprazan glurate - Safety, Bioavailability | Phase 1 | Completed | Cinclus Pharma Holding AB | 67 | 2022-11-15 | 2025-04-03 |
| Bioavailability of EPA/DHA in of Ruby-O and Krill Oil EPA + DHA Ruby-O, EPA + DHA Krill Oil - Bioavailability | Not applicable | Completed | Midwest Center for Metabolic and Cardiovascular Research | 28 | 2022-07-11 | 2022-12-01 |
| Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule - Bioavailability | Phase 1 | Completed | Exeltis Turkey | 18 | 2022-05-09 | 2025-02-07 |
| Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants PF-07321332/ritonavir - Bioavailability | Phase 1 | Completed | Pfizer | 12 | 2022-03-10 | 2024-06-06 |
Showing 20 of 88. Sign in to see all of them.
COVID-19 (2) · Anemia (1) · Anemia, Iron-Deficiency (1) · Cardiovascular Diseases (1) · Critical Illness (1) · Fasting (1) · Graves Ophthalmopathy (1) · HIV Infections (1) · Malaria (1) · Multiple Endocrine Neoplasia Type 1 (1) · Smoking Cessation (1)
Infections (4) · RNA Virus Infections (3) · Virus Diseases (3) · Behavior (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Endocrine System Diseases (2) · Genetic Diseases, Inborn (2) · Immune System Diseases (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · Respiratory Tract Diseases (2)
Excipients (2) · Famotidine (2) · Melatonin (2) · Solutions (2) · Transdermal Patch (2) · Water (2) · mirabegron (2) · naloxegol (2) · nirmatrelvir and ritonavir drug combination (2) · 5-methyltetrahydrofolate (1) · Akacid-medical-formulation (1) · Anthocyanins (1) · Ascorbic Acid (1) · Capsules (1) · Coffee (1)
AstraZeneca (6) · Maastricht University Medical Center (4) · Pfizer (4) · Midwest Center for Metabolic and Cardiovascular Research (3) · ESM Technologies, LLC (2) · INSYS Therapeutics Inc (2) · Labopharm Inc. (2) · Medicines for Malaria Venture (2) · Perrigo Company (2) · University of Maryland, Baltimore (2) · APR Applied Pharma Research s.a. (1) · Amgen (1) · Anklam Extrakt (1) · Astellas Pharma Europe B.V. (1) · Astellas Pharma Inc (1)
United States (32) · Canada (7) · Netherlands (7) · Germany (6) · United Kingdom (5) · Spain (4) · China (2) · Denmark (2) · Israel (2) · Burkina Faso (1) · Hong Kong (1) · India (1) · Italy (1) · Singapore (1) · Slovenia (1)
Cees Vermeer, PhD (3) · Kevin C Maki, PhD (3) · Audra L Stinchcomb, PhD (2) · Rainard Fuhr, Dr. med. (2) · Aedin Cassidy, PhD (1) · Ashima Bhatia, MD (1) · Benoit Deschamps, MD (1) · Bo Fransson, MD (1) · Carlos Prendes, MD (1) · Dale R Wilson, MD (1) · Daniel Menzel, MD (1)
PMID 19774117, PMID 20051587, PMID 24432743, PMID 27512620, PMID 29430278, PMID 30454850, PMID 31684927, PMID 32353962, PMID 32757149, PMID 37231296, PMID 38753174, PMID 38918235
2015 (1)